November 2, 2026

News, minutes after it breaks

Business
Latest
Shadowy Indian election ‘consultants’ add US midterms to global footprintHebron governor says Israeli forces withdraw from city after 10-day siegeTransfer rumors, news: Man United meltdown edition. Balogun the latest to be linkedChristmas donations gift demand up, charities sayWoman who flew with swans warns of lead dangerChristmas shoebox appeal launches to help childrenLive: Russia and Ukraine trade blame for cyber attacks as fragile ceasefire endsVerdict delayed on controversial sea defencesShadowy Indian election ‘consultants’ add US midterms to global footprintHebron governor says Israeli forces withdraw from city after 10-day siegeTransfer rumors, news: Man United meltdown edition. Balogun the latest to be linkedChristmas donations gift demand up, charities sayWoman who flew with swans warns of lead dangerChristmas shoebox appeal launches to help childrenLive: Russia and Ukraine trade blame for cyber attacks as fragile ceasefire endsVerdict delayed on controversial sea defences

Home  / Business

Sickle cell gene therapies offer new hope, but access remains a major challenge

Business CNBC
Image: CNBC

FDA-approved gene therapies for sickle cell disease offer a chance to help patients, but factors including cost and access have slowed their use.

CNBC reported this story. Read the full report on cnbc.com →

This is a short summary. CNBC wrote and published the full report.

Continue on cnbc.com →

More in Business

Leave a Reply

Your email address will not be published. Required fields are marked *